Allergan Gets FDA Approval for Using Botox To Treat Overactive Bladders
Posted Aug 25 2011 12:19am
Botox seems to be a shining star for relief in many areas of late and last year another type of botox was approved to treat cervical dystonia. In March of last year the FDA also approved the use for muscle spasms in the hand and wrist area. BD
Allergan Inc. won U.S. clearance to market the wrinkle smoother Botox as a treatment for urinary incontinence.
The Food and Drug Administration approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement . The medicine is injected into the bladder to increase its capacity by relaxing muscles.
Botox, also used to reduce facial wrinkles and treat neurological disorders, is the Irvine, California-based company’s top product with $1.4 billion in revenue last year. Sales of the drug for incontinence in people with MS and spinal cord injuries may reach $40 million in 2017, Seamus Fernandez , a Boston-based analyst at Leerink Swann & Co., said today in a note to investors.
Botox seems to be a shining star for relief in many areas of late and last year another type of botox was approved to treat cervical dystonia. In March of last year the FDA also approved the use for muscle spasms in the hand and wrist area. BD
Botox gives grandmother her voice back